Shares of Infosys Ltd (INFY) spiked in pre-market trading on Friday after the software company posted second quarter earnings and revenues that beat Wall Street expectations.
The India-based company posted a second quarter net income of $383 million, or 67 cents per share, down from $431 million, or 75 cents per share, posted in the same period last year.
The company’s earnings per American Depository Share, or ADR, came in at 73 cents per share. According to analysts at Thomson Reuters, the company was expected to earn 70 cents per share in the quarter.
10 Best Heal Care Stocks To Invest In 2015: American States Water Co (AWR)
American States Water Company (AWR), incorporated on February 25, 1998, is the parent company of Golden State Water Company (GSWC) and American States Utility Services, Inc. (ASUS) and its subsidiaries (Fort Bliss Water Services Company (FBWS), Terrapin Utility Services, Inc. (TUS), Old Dominion Utility Services, Inc. (ODUS), Palmetto State Utility Services, Inc. (PSUS) and Old North Utility Services, Inc. (ONUS)). AWR operates in three segments: water, electric and contracted services. Within the segments, AWR has two principal business units, water and electric service utility operations, conducted through GSWC, and contracted services conducted through ASUS and its subsidiaries.
GSWC is a California public utility company engaged principally in the purchase, production and distribution of water in 75 communities in 10 counties in the State of California. GSWC also provides electric service to the City of Big Bear Lake and surrounding areas in San Bernardino County, California through its Bear Valley Electric Service (BVES) division. GSWC served 255,657 water customers and 23,379 electric customers as of December 31, 2012. ASUS, through its wholly owned subsidiaries, has contracted with the United States government to provide water and/or wastewater services at various military installations, including the operation, maintenance, renewal and replacement of the water and/or wastewater systems, pursuant to 50-year firm, fixed-price contracts. As of December 31, 2012, GSWC�� physical properties consisted of water transmission and distribution systems which included 2,786 miles of pipeline together with services, meters and fire hydrants and approximately 425 parcels of land.
As of December 31, 2012, GSWC owned 244 wells, of which 188 are active operable wells equipped with pumps with an aggregate production capacity of approximately 202.7 million gallons per day. GSWC has 63 connections to the water distribution facilities of the Metropolitan Water District of Southern Cali! fornia (MWD), and other municipal water agencies. GSWC�� storage reservoirs and tanks have an aggregate capacity of approximately 111 million gallons. GSWC owns no dams. GSWC�� electric properties are located in the Big Bear area of San Bernardino County, California. As of December 31, 2012, GSWC owned and operated 29.6 miles of overhead 34.5 kilovolt transmission lines, 1.4 mile of underground 34.5 kilovolt transmission lines, 179.6 miles of 4.16 kilovolt or 2.4 kilovolt distribution lines, 53.2 miles of underground cable, 13 sub-stations and a natural gas-fueled 8.4 megawatt peaking generation facility. GSWC also has franchises, easements and other rights of way for the purpose of constructing and using poles, wires and other appurtenances for transmitting electricity.
Advisors' Opinion:- [By Richard Band]
American States Water (AWR) provides water service to one of 36 Californians throughout the northern, coastal and southern regions of the state.
In their recent earnings report, AWR showed an 11.1% increase in diluted earnings per share, but revenues fell short of analyst estimates by 2% due to an increase in the effective income tax rate for the company’s water segment.
- [By Michael Flannelly]
On Tuesday, analysts at Brean Capital upgraded American States Water Co (AWR), as they now believe the shares have reached an attractive entry point.
The analysts upgraded AWR from “Hold” to “Buy” and see shares reaching $28. This price target suggests an 11% upside to the stock’s Monday closing price of $25.22.
Brean Capital analyst Michael Gaugler said, “The shares have fallen to a price level that we now consider attractive, and our sum-of-the-parts valuation indicates fair value is $28 based on our 2014 EPS forecasts. We recommend investors begin accumulating positions under the $25.50 price level to allow sufficient (10%) upside (excluding dividends) to our target price.”
“We acknowledge that the current environment for utility stocks in terms of interest rate impacts is less than ideal. However, we note the shares of AWR (and our other utility coverage names) have traded at higher P/E multiples when the general level of interest rates was much higher. We see the impact of higher rates as short term and negligible, particularly when we look closely at AWR’s ability to continue to raise its dividend payout versus the peer group by using free cash flow from the ASUS business,” Gaugler added.
American States Water shares were up 72 cents, or 2.85%, during early morning trading on Tuesday. The stock is up 8% year-to-date.
Hot Income Stocks To Invest In Right Now: Neurocrine Biosciences Inc.(NBIX)
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.�r.l. to develop and commercialize elagolix and GnRH antagonists for women?s and men?s health indications; and Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Ben Levisohn]
Yes, say the folks at Nomura, who recommend buying�Celgene (CELG), Receptos
(RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya and team explain why: - [By John Udovich]
Yesterday, small cap biopharmaceutical stock Neurocrine Biosciences, Inc (NASDAQ: NBIX) surged 89.69% after announcing positive results for its VMAT2 inhibitor NBI-98854 as a treatment for tardive dyskinesia, meaning investors late to the party or those already in should take a closer look at the stock along with its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By Jake L'Ecuyer]
Equities Trading UP
Shares of Neurocrine Biosciences (NASDAQ: NBIX) got a boost, shooting up 57.43 percent to $15.37 after the company reported positive results of VMAT2 inhibitor NBI-98854 in Kinect 2 study. - [By Lisa Levin]
Neurocrine Biosciences (NASDAQ: NBIX) shares moved up 76.95% to $17.27. The volume of Neurocrine Biosciences shares traded was 4406% higher than normal. Neurocrine Biosciences reported positive results of VMAT2 inhibitor NBI-98854 in Kinect 2 study.
Hot Income Stocks To Invest In Right Now: Stream Group Ltd (SGO)
Stream Group Limited, formerly LongReach Group Limited, is an Australia-based company operating in the information and communications technology (ICT) sector. The Company is engaged in the design, integration, installation and maintenance of integrated information and communications technology based products and services to the defense, public safety and security sectors, as well as for government, telecommunications and corporate customers, both locally and internationally. The Company together with its subsidiaries is also engaged in the provision of consulting services to certain key defense organizations. In January 2013, the Company sold its C4i business. Advisors' Opinion:- [By Jonathan Morgan]
Saint-Gobain (SGO) dropped 3.7 percent to 36.87 euros. Morgan Stanley cut its rating on the stock to underweight, similar to a sell recommendation, from equal weight, saying it doesn�� see a recovery yet in the European building industry and the contribution from emerging markets will slow.
Hot Income Stocks To Invest In Right Now: Take-Two Interactive Software Inc.(TTWO)
Take-Two Interactive Software, Inc. publishes, develops, and distributes interactive entertainment software, hardware, and accessories worldwide. The company develops and publishes software titles for various gaming and entertainment hardware platforms, including PlayStation3 and PlayStation2 computer entertainment systems, PlayStation Portable system, Xbox 360 video game and entertainment system, and Wii and DS systems, as well as for the personal computer and games for Windows. It offers products through its wholly owned labels Rockstar Games and 2K, which publishes titles under 2K Games, 2K Sports, and 2K Play. The company, through its subsidiary, Jack of All Games, also distributes software, hardware, and accessories in North America. Its proprietary brand franchises include Grand Theft Auto; Sid Meier's Civilization; Max Payne; Midnight Club; Manhunt; Red Dead Revolver; Bully; BioShock; Sid Meier's Railroads!; Sid Meier's Pirates!; Carnival Games; and Top Spin, as wel l as licensed brands comprise the sports games Major League Baseball 2K; NBA 2K; and NHL 2K. The company sells its software titles to retail outlets through direct relationships with large retail customers and third party distributors. Its customers include mass merchandisers, specialty retailers, video stores, electronics stores, toy stores, national and regional drug stores, and supermarket and discount store chains. The company was founded in 1993 and is headquartered in New York, New York.
Advisors' Opinion:- [By Eric Volkman]
The top and bottom lines have improved for Take-Two Interactive (NASDAQ: TTWO ) , which has released its Q4 and fiscal 2013. For the quarter, net revenue was just under $300 million, more than double the $148 million the video-game company posted in the same period the previous year. The bottom line flipped to a profit of $22 million ($0.24 per diluted share) from Q4 2012's net loss of $67 million ($0.79).
- [By Jon C. Ogg]
Take-Two Interactive Software Inc. (NASDAQ: TTWO) is up by less than 1% despite being touted in Barron’s over the weekend. The financial publication showed that more good is coming here and that shares could rise by another 30%. The only point we might make is that video game stocks already are�seeing such high gains ahead of the Xbox One and PlayStation 4 that we cannot help but wonder if all the good news has been priced in even before the new consoles hit the retail shelves.
- [By DailyFinance Staff]
Sales of video games and consoles have been sluggish, but shares of the game makers are soaring. The research group NPD reports that domestic sales of video games by retailers fell nearly 10 percent in the first-quarter. But investors are overlooking some middling performance and focusing on what they hope will be an exciting future. So far this year, shares of Activision Blizzard (ATVI) and Take-Two Interactive (TTWO) have both soared by more than 40 percent. Industry leader Electronic Arts (EA) is up 24 percent. And retailer Gamestop (GME) has beat them all, up 49 percent since the beginning of the year. Electronic Arts and Activision will report first quarter results this week, and analysts aren't expecting anything special. Invision for Xbox/AP Images So what's driving the stocks higher despite so-so performance? It's the expectation for a new round in the console war, with new Xbox and PlayStation models rolling out in time for the holidays. Microsoft (MSFT) is expected to unveil the new Xbox on May 21st. And we already know Sony's (SNE) PlayStation 4 will have touch-sensing controllers and a 'share' button to allow gamers to live-cast their play to friends. Sony is likely to release more details at next month's E3 videogame conference. In the meantime, though, console sales have slumped as gamers await the new models, or anticipate that current models will be deeply discounted. As for the game makers, they've had some high profile releases this year. EA has "Crysis 3" and "Dead Space 3". Analysts will be watching sales of those games when the company reports. EA has also been dealing with the surprise resignation in mid-March of its CEO. The company has not yet named a replacement. And the company warned that its earnings for the first-quarter were likely to fall short of Wall Street expectations. A fourth video game maker, THQ, filed for bankruptcy in December, and it's in the process of selling of its business in parts. The tepid offering of
- [By Wallace Witkowski]
Stock in Take-Two Interactive Software Inc. (TTWO) �declined 4.4% to $19.72 on moderate volume as investors also weighed a quarterly earnings beat with a poor outlook.
Hot Income Stocks To Invest In Right Now: St. Jude Medical Inc.(STJ)
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:- [By Dan Carroll]
Why is this important? Medtronic's battling with Edwards Lifesciences's (NYSE: EW ) Sapien heart valve for market share in Europe, and upstarts Boston Scientific (NYSE: BSX ) and St. Jude Medical (NYSE: STJ ) are looking to punch into the European industry with their Lotus and Portico valves, respectively. Medtronic's valve-in-valve approval gives the company a leg up on its competition, but is it enough to entrench this firm as a leader in the industry? Motley Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what you need to know below.
- [By Max Macaluso, Ph.D.]
Shares of medical-device maker St. Jude Medical (NYSE: STJ ) climbed more than 5.2% today after the company reported its second-quarter results. While net sales were down slightly compared to the same quarter last year, the company's revenue and earnings per share beat estimates and impressed investors.
Hot Income Stocks To Invest In Right Now: Lydall Inc. (LDL)
Lydall, Inc. designs and manufactures specialty engineered products for the thermal/acoustical, filtration/separation, and bio/medical applications worldwide. The company operates through Performance Materials, Thermal/Acoustical Metals, and Thermal/Acoustical Fibers segments. The Performance Materials Segment offers filtration media solutions for air, fluid power, and industrial applications, such as clean-space, commercial, industrial and residential HVAC, power generation, and industrial processes. This segment also provides industrial thermal insulation media and products for the cryogenic, building products, appliance, and high temperature insulation markets. In addition, it offers life sciences filtration products for life science applications, including biopharmaceutical pre-filtration and clarification, diagnostic and analytical testing, respiratory protection, life protection, medical air filtration, drinking water filtration, and high purity process filtration. T he Thermal/Acoustical Metals segment provides engineered products, such as thermal and acoustical shielding solutions to assist in noise and heat abatement within the transportation sector. The Thermal/Acoustical Fibers segment offers thermal and acoustical insulating solutions comprising organic and inorganic fiber composites for the automotive and truck markets. The company also provides specialty products for blood filtration devices and blood transfusion single-use containers; and designs and manufactures single-use solutions for cell growth, frozen storage, and fluid handling, as well as equipment for bioprocessing applications. Lydall sells its products primarily to original equipment manufacturers and tier-one suppliers. The company was founded in 1913 and is based in Manchester, Connecticut.
Advisors' Opinion:- [By Lisa Levin]
Conglomerates: This industry moved up 8.21% by 11:30 am. The top performer in this industry was Lydall (NYSE: LDL), which gained 2%. Lydall is expected to report its Q3 earnings on November 5, 2014.
Hot Income Stocks To Invest In Right Now: Lexmark International Inc.(LXK)
Lexmark International, Inc., together with its subsidiaries, engages in the development, manufacture, and supply of printing, imaging, document workflow, and content management solutions for offices in North and South America, Europe, the Middle East, Africa, Asia, the Pacific Rim, and the Caribbean. It offers monochrome and color laser printers, laser multifunction products, inkjet all-in-one devices, dot matrix printers, and cartridges and other supplies; and services and solutions, including maintenance, consulting, and systems integration, as well as managed print services, such as asset lifecycle management, implementation and decommissioning services, consumables management, optimization services, and utilization management. The company also provides enterprise content management (ECM) software products, including ImageNow document management, document imaging, and workflow suite that allows users to capture, process, and collaborate on important documents and inform ation, protect data integrity throughout its lifecycle, and access precise content; and industry specific workflow solutions for the healthcare, higher education, government, and financial services industries, as well as for back office functions, including accounting, human resources, contracts, and records. Its software modules include Retention Policy Manager to manage the complete lifecycle of content from creation to destruction or disposition; Business Insight, which integrates IBM Cognos to provide industry and business process dashboards, operational and ad-hoc reporting, and report design tools; workflow software that automates processing steps, simplifies work tasks, and provides real-time monitoring; and eForms module, which enables the online entry and collection of raw data in electronic forms that are accessible from Web sites and portals. The company was founded in 1990 and is headquartered in Lexington, Kentucky.
Advisors' Opinion:- [By Lee Jackson]
Lexmark International Inc. (NYSE: LXK) is another name that has slowly, but surely, lost its cache as an industry leader. Once one of the premiere names in high-end printers, the company continues to lose market share. It also has very little to offer in terms of innovation and new and exciting products. The stock does pay shareholders a solid 2.9% dividend. The Merrill Lynch price target is $31, and the consensus price target is $31.75. That is far below Friday’s closing price of $41.12.
- [By Rich Duprey]
Printer maker�Lexmark (NYSE: LXK ) announced yesterday its third-quarter dividend of $0.30 per share, the same rate it's paid for the past five quarters after raising the payout 20% from $0.25 per share.
No comments:
Post a Comment